Executive Committee: BioXcel Therapeutics

Manager
Positions heldSince
Vimal Mehta

Vimal Mehta

64 year

Chief Executive Officer 2017-04-30
Founder 2017-03-28
President 2017-04-30
Richard Steinhart

Richard Steinhart

67 year

Comptroller/Controller/Auditor 2017-09-30
Director of Finance/CFO 2017-09-30
Frank Yocca

Frank Yocca

69 year

Chief Tech/Sci/R&D Officer 2017-05-31
Vincent O'Neill

Vincent O'Neill

56 year

Chief Tech/Sci/R&D Officer 2017-06-30
Chetan Lathia

Chetan Lathia

General Counsel -
Javier Rodriguez

Javier Rodriguez

53 year

General Counsel 2021-02-22
Corporate Secretary 2021-02-22
Brennan Doyle

Brennan Doyle

Investor Relations Contact -

Composition of the Board of Directors: BioXcel Therapeutics

Director
CommitteesSince
Peter Mueller

Peter Mueller

69 year

Audit Committee 2017-07-31
Compensation Committee Chair 2017-07-31
Governance Committee Chair 2017-07-31
Nominating Committee Chair 2017-07-31
Michael Miller

Michael Miller

68 year

Compensation Committee
Governance Committee 2018-02-22
Nominating Committee 2018-02-22
Audit Committee 2022-06-30
Sandeep Laumas

Sandeep Laumas

57 year

Compensation Committee 2017-12-31
Governance Committee 2017-08-31
Nominating Committee 2017-08-31
Audit Committee Chair 2017-12-31
June Bray

June Bray

71 year

Governance Committee 2021-02-28
Nominating Committee 2021-02-28
Audit Committee 2022-06-08
Michal Votruba

Michal Votruba

59 year

Audit Committee 2019-03-17
Governance Committee Chair 2019-03-17
Nominating Committee Chair 2019-03-17
Rajiv Patni

Rajiv Patni

56 year

Compensation Committee 2024-02-14
David Mack

David Mack

54 year

Compensation Committee 2024-11-20
Vimal Mehta

Vimal Mehta

64 year

Director/Board Member 2017-03-31

Former Officers and Directors: BioXcel Therapeutics

Insider
Positions held
SinceUntil
Matthew Wiley
Matthew Wiley
Corporate Officer/Principal 2022-01-18 2024-10-01
Krishnan Nandabalan
Krishnan Nandabalan
Director/Board Member 2017-04-30 2023-09-18
Corporate Officer/Principal 2019-12-31 2023-09-18
William Kane
William Kane
Corporate Officer/Principal 2020-06-15 2021-10-07
Reina Benabou
Reina Benabou
Corporate Officer/Principal 2020-06-22 2021-07-29
David Hanley
David Hanley
Corporate Officer/Principal 2018-09-03 2021-04-30
Chids Mahadevan
Chids Mahadevan
Comptroller/Controller/Auditor 2017-05-31 2019-11-30
Cedric Burg
Cedric Burg
Corporate Officer/Principal 2018-06-12 -
Mary Coleman
Mary Coleman
Investor Relations Contact - -
Kimberly Sheehan
Kimberly Sheehan
Human Resources Officer - -
Iris Francesconi
Iris Francesconi
Sales & Marketing - -

Age distribution of managers

Parity Men Women

Male 14
Female 1

Of which Executive Committee

Male 7
Female 0

Of which Directors

Male 7
Female 1

Revisions

1 year Revenue revision
-
4 months Revenue revision
-
1 months Revenue revision
-
1 year EPS revision
-
4 months EPS revision
-
ESG MSCI
BB

ESG

Environment
Social
Governance
Controversy
ESG: Ethical controversies
-
ESG: Human rights controversies
-
ESG: Tax subsidies controversies
-
Sharia compliant
-
Logo BioXcel Therapeutics
BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence to develop medicines in neuroscience. Its subsidiary, OnkosXcel Therapeutics, develops medicines in immuno-oncology. The Company’s most advanced neuroscience candidate, BXCL501, is an investigational, proprietary, orally dissolving film formulation of Dex in development for the treatment of agitation associated with psychiatric and neurological disorders. It is continuing to develop BXCL501 for the potential acute treatment of agitation associated with bipolar disorders or schizophrenia in the at-home setting and for the potential acute treatment of agitation (non-daily) associated with dementia due to probable Alzheimers disease in the at-home setting and in care facilities. Its most advanced immuno-oncology candidate, BXCL701, is an investigational oral innate immune activator for the treatment of aggressive forms of prostate cancer, pancreatic cancer, and other solid and liquid tumors.
Employees
74
Sector
-
More about the company